Huma is a global health technology company with a modular platform that combines predictive algorithms, digital biomarkers, and data with a mission to advance predictive care and research. Aiming to help people live longer and healthier lives, the company features remote patient monitoring and companion apps for pharma and medical technology workers. Huma was founded by Dan Vahdat and Rich Khatib in 2011 and is headquartered in London, UK.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
04/04/2024 | Series D-2 | $26.03MM | $xx.xx | $731.49MM | Bayer, Touchstone Investment | |
Price per Share
$xx.xx
Shares Outstanding
1,422,245
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bayer, Touchstone Investment
|
||||||
04/04/2024 | Series D-1 | $20.25MM | $xx.xx | $731.49MM | Bayer, Ireon Ventures, Minamour Investments, Touchstone Investment | |
Price per Share
$xx.xx
Shares Outstanding
885,051
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bayer, Ireon Ventures, Minamour Investments, Touchstone Investment
|
||||||
05/11/2021 | Series C | $90.87MM | $xx.xx | $605.82MM | Bayer, Hat, Hitachi Ventures, Michael Diekmann, Nikesh Arora, Samsung Next, Sony Ventures, Unilever Ventures | |
Price per Share
$xx.xx
Shares Outstanding
4,151,557
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bayer, Hat, Hitachi Ventures, Michael Diekmann, Nikesh Arora, Samsung Next, Sony Ventures, Unilever Ventures
|